LightPath $100M Offering Adds Heavy Dilution and Insider Selling

What happened

LightPath Technologies announced a $100 million registered direct offering of 7.14 million shares at $14.00 per share, with $50 million going to the company and the other half to selling stockholder North Run Strategic Opportunities Fund. This follows a 340% stock surge over the past year and a $60 million equity raise just six months ago, signaling relentless dilution. The company remains GAAP-unprofitable with negative free cash flow, and the secondary component reveals an insider cashing out, not just funding growth. Even at the offering price, the stock trades at roughly 16x trailing revenue with no proven path to sustainable profitability. The deal provides near-term liquidity but deepens the capital structure overhang, making a tricky risk-reward profile even worse.

Implication

Over 6-12 months, the company's ability to convert its ~$90M backlog into positive EBITDA and free cash flow will determine if the dilution was worth it. If margins disappoint, the stock could retreat toward the $7-11 base/bear case range.

Thesis delta

The prior thesis already flagged excessive valuation and execution risk. The $100M offering—especially the insider-led secondary—reinforces the bear case by adding dilution and showing a key investor reducing exposure. Valuation now seems even more stretched against deteriorating per-share metrics, increasing the likelihood of multiple compression.